ABSTRACT The role of phenomena analogous to fibroblast contact inhibition in lymphocyte growth regulation is controversial, although it is clear that direct cell-cell contact is vital to immunoregulation and accessory cell function. An extract of mouse liver plasma membrane proteins, referred to as suppressive liver extract (SLE), that suppresses the growth of 3T3 fibroblasts also inhibited the mitogen-induced proliferation of murine lymphocytes. A dose of 20 /~g/ml SLE was >95% suppressive of proliferation in both mouse T and mouse B cells treated with a variety of mitogens. B cell growth factor, while increasing DNA synthesis overall in mitogen-stimulated B cells, did not change the extent of SLE suppression, which suggests that the SLE does not interfere with lymphocyte-growth factor interactions. In exploring a sequence of B cell activation events, we discovered that SLE had no effect on the early activation event of increased phosphatidylinositol turnover. Blastogenesis, however, was inhibited in mitogen-stimulated, SLE-treated B cells. The maximum suppressive effect was observed if the SLE was added within 8-12 h of the mitogenic stimulus. SLE did not affect the viability of cells in culture. These results point to a possible unity of regulatory mechanisms between contact inhibition in fibroblasts and the processes of immunoregulation.
Regulation and control of celt proliferation is poorly understood. One approach to understanding the regulation of cell growth has been the study of the density-dependent inhibition of fibroblast proliferation. Fibroblasts, when grown to confluency in culture, cease dividing while retaining viability. The challenge has been to ascertain the nature of the factor or factors responsible for this growth regulation (1) . In this regard, it has been demonstrated that peptide factors that regulate cell growth are located on the cell surface. Both growth inhibitory and growth stimulatory factors have been identified in preparations of plasma membranes from cultured mouse and human fibroblasts (1) (2) (3) (4) , cultured rat hepatocytes (5) , and mouse liver (6) . Cells released from "normal" growth regulation (transformed cells) express these factors on their cell surfaces but do not respond to them (1, 6, 7) . The growth inhibitory membrane factors appear to act by reversibly halting the progression of fibroblasts through the G1 phase of the cell cycle at the same point as serum deprivation (8, 9) . These inhibitory factors also induce other responses normally associated with high cell density growth arrest, such as an increase in the number of receptors for epidermal growth factor (10) and the induction of tyrosine aminotransferase in hepatocytes (11). The contention that these factors are actually peptides is supported by the observation that their suppressive action on fibroblasts is heat and acid labile (1, 8) , and the further indication that the activity of the solubilized product is not affected by total delipidation (12) .
One system in which cell-cell interactions are thought to play a significant role in growth regulation is the immune system. This system requires that immunocompetent lympocytes be in a resting state (GO) until triggered by appropriate stimuli. The lymphocytes then enter the cell cycle, during which they enlarge in size, proliferate, and reach terminally differentiated functional status. Each stage of this progression is critically regulated by interactions between lymphocytes, as well as between these cells and accessory cells such as monocytes and dendritic cells. The purpose of this study was to detemine if the presence of exogenous growth inhibitory factor obtained from mouse liver membranes inhibited the mitogenic response of murine T and B lymphocytes. Mouse liver membrane extracts inhibit fibroblast growth (6) ; this indicates inhibitory cross-reactivity between these two different cell types. The demonstration of inhibition of lymphocyte proliferation would be consistent with the notion that this system of inhibitory growth regulation has general applicability across a wide range of cell types. Our results indicate that suppressive liver extract (SLE) ~ from mouse liver blocked the mitogeninduced proliferation of mouse T and B cells. This effect was labile to heat treatment and resistant to delipidation of the SLE. The maximum inhibitory effect of the SLE occurred within 12 h of mitogenic stimulus. Because of this, we also examined the effect of SLE on an early event, namely phosphatidylinositoi turnover. The early activation of phosphatidylinositol metabolism, which is an early event in cell activation in both T ( 13, 14) and B (15) cells, was not significantly influenced by SLE. These results indicate possible similarity of mechanisms between contact inhibition and lymphocyte growth regulation.
MATERIALS AND METHODS

Mice:
Male BALB/c mice were obtained from Harlan Sprague Dawley, Inc., Indianapolis, IN, and were used between 6 and 12 wk of age.
Lymphocyte Isolation and Purification: B cells were isolated from mouse spleen and purified as described previously (15) . Briefly, spleens were harvested from mice treated with anti-thymocyte serum (M. A. Bioproducts, Walkersville, MD), the cells isolated, and the erythrocytes lysed. The splenocytes were then depleted of adherent cells (primarily monocytes) by incubation for l h at 37"C in glass petri dishes (20 ml/plate) at 2 x l06 cells/ ml in RPMI 1640 plus penicillin/streptomycin, glutamine (complete medium), and 10% fetal bovine serum (FBS). The remaining T cells were depleted by treatment with cytotoxic monoclonal antibodies to T cell markers, anti-thymocyte serum, and complement. Cells thus treated were >90% positive for surface ig and had <5% T cells as determined by flow cytometric analysis. Mouse T cells were isolated from spleens of untreated mice after erythrocyte lysis and glass plate adherence. Viabilities of cells used as determined by the method of fluorescein/ethidium bromide staining (16) were always in excess of 90%.
Assay of DNA Synthesis: Mouse T cells were suspended in complete medium plus 10% FBS at 10 ~ cells/0.24 ml/well in 96-well microtiter plates (Corning Glass Works, Coming, NY). Mouse enriched B cells were suspended in the same medium with 300 vM beta-mercaptoethanol at 2 x 105 cells/0.24 ml/well. Mitogens were added to cultures at time zero, (3H-methyl)thymidine (SH-TdR) ( 1 vCi/well, 6.7 Ci/mmole) (ICN K & K Laboratories Inc., Plainview, NY) was added at 62 h, and the cultures were harvested at 72 h on glass fiber filter strips. All incubations were at 37"C in a 5% CO2 atmosphere. Total 3H-TdR incorporation was determined by liquid scintillation spectrometry using 2 ml of scintillation cocktail 4a20 (Research Products International Corp., Mr. Prospect, IL). Each data point was obtained in triplicate. Percentage suppression was calculated as incorporation at a given suppressive dose divided by control incorporation (mitogen in the absence of SLE). Phosphatidylinositolmetab- olism in B cells was assayed as described elsewhere (15) . Briefly, enriched B cells were suspended in phosphate-free complete medium plus 2% phosphatefree FBS (FBS was dialzyed extensively against phosphate-free medium) at 2 x 106 cells/ml in 1-ml tube cultures, treated with 50 ug/ml anti-lgM, and then incubated at 37"C. 100 #Ci 32pi (1CN K & K Laboratories Inc.) was added 2 h before harvest, at which time the cells were washed and the phospholipids extracted by a modified Folch extraction (17) . The extracted lipids were chromatographed on oxalate-treated high performance thin layer chromatography plates (MCB Reagents, Gibbstown, NJ) in a tank equilibrated with a solvent system of chloroform, acetone, methanol, acetic acid, and water (40:15:13:12:8, vol/vol) for 3.5 h (18). Phospholipid standards (Sigma Chemical Co., St. Louis, MO) were added to cell lipid extracts and visualized in an iodine tank to confirm the equilibrium position of each phospholipid species. Autoradiograms were obtained and the spots corresponding to each phospholipid species were scraped off and counted in a liquid scintillation counter as described above.
Assay of Phospholipid Metabolism:
Cell Size Characterization: Cells were cultured at 37"C in 24-well cluster plates (Corning Glass Works) at 106 cells/ml/well complete medium plus 10% FBS. The cells were resuspended at various times after mitogen and SLE addition, and 0.2 ml of the resuspended cells was added to 9.8 ml of Isoton J Abbreviations used in this paper." BCGF, B cell growth factor; FBS, fetal bovine serum; 3H-TdR, (3H-methyl)thymidine; LPS, lipopolysaccharide; SLE, suppressive liver extract.
for cell size analysis on a Coulter Model ZM Counter/Channelizer (Coulter Electronics Inc., Hialeah, FL). The data were analyzed and stored on an Apple IIe microcomputer.
Mitogens: For the T cells, phytohemagglutinin (Sigma Chemical Co.) and concanavalin A (Sigma Chemical Co.) were used at l0 ~g/ml and 3 t@/ ml, respectively. For the B cells, E. coli lipopolysaccharide (LPS) 055:b5 (W) (Difco Laboratories Inc., Detroit, MI) and the F(ab')2 fragment of goat antimouse IgM (mu chain specific) (CooperBiomedical, Inc., Malvern, PA) were each used at 50 ~g/ml. B cell growth factor (BCGF) activity was obtained from conditioned media of EL-4 cells, a murine thymoma that produces BCGF ( 19, 20) . EL-4 cells were cultured at l06 cells/ml in complete medium plus 1% FBS with l0 ng/ml phorbol myristate acetate. After 48 h at 37"C, the medium was centrifuged and the supernatant collected and passed over activated charcoal. This conditioned medium contained BCGF activity with no IL-2 activity, as assayed with mouse enriched B cells and the IL-2 dependent line CTLL-2 (21 ).
Preparation of SLE from Mouse Liver: Mouse liver membranes
were prepared following the protocol devised by Aronson and Toaster for the preparation of rat liver membranes (22) . This procedure consists of cell homogenization by a motor-driven teflon pestle, differential low speed centrifugations to remove nuclei and whole cells, and flotation of various membrane fractions in a discontinuous high speed sucrose gradient. The original procedure described the isolation of membrane-rich fractions from both cell and nuclei: for the studies described in this paper only cellular membranes were collected. Typical membrane preparations showed a 10-15-fold enrichment for a plasma membrane marker (alkaline phosphodiesterase) with very little enrichment for any other organelle. Membrane could be stored at -70"C for up to 6 mo without any appreciable loss of growth inhibitory activity. Membranes prepared in this fashion have been shown to contain both growth stimulatory and growth inhibitory activities when added to mouse fibroblasts in culture (6) .
Soluble growth inhibitory fractions were prepared by first extracting the membranes three times with 0.13 M sodium pyrophosphate/0.1 mM dithiothreitol, pH 7.4, for 60 minutes at 4"C. Such extractions remove a growth stimulatory activity from the membrane (6) while leaving the inhibitory component in the membrane. The pyrophosphate-treated membranes were then extracted with dimethyl maleic anhydride as described by Raben et al. (12) for solubilization of a 3T3 cell growth inhibitory factor. Briefly, membranes at 160 ug/ml in 0.7 mM Tris-HC1, 0.07 mM EDTA, had dimethyl maleic anhydride added to 2 mg/ml final concentration after adjusting the pH to 8.5 with 1 N NaOH. The pH was kept at 8-8.5 by the addition of I N NaOH as the reaction proceeded. When acid evolution stopped (after ~45 min), the membranes were recovered by centrifugation and solubilized by the addition of 30 mM octylglucoside in 10 mM potassium phosphate, 0.1 mM dithiothreitol, pH 7.4 (octylglucoside buffer), and incubated for 45 min at 4"C at a protein concentration of 0.63 mg/ml. Centrifugation at 50,000 g for 45 min then clarified the extract, and the supernatant was treated with 0.1 vol of 1 M sodium acetate, pH 4.0. This procedure precipitates the growth inhibitory activity as well as removes any dimethylmaleyl groups which may be on the membrane. Centrifugation (50,000 g for 45 min) recovered the pellet which was solubilized a second time with octylgiucoside as described above. The resultant supernatant was then dialyzed extensively against 5 mM HEPES, 0.1 mM dithiothreitol, pH 7.4 (buffer A), and stored at -70°C until use. Such preparations contain both protein and some lipid, and remain active for as long as 12 mo under these conditions (6) . Fractions that contained soluble inhibitor were brought to isotonicity by addition of l0 x medium and added to the cells in microtiter wells.
Delipidation of the Solubilized Inhibitor: Lipid was removed
from the solubilized material by the procedure of Dean and Tanford (23) as described by Raben et al. (12) . Soluble inhibitor, obtained as described above and still in the presence of octylglucoside, was precipitated by the addition of 0. l vol of I M sodium acetate, pH 4.0, and the resulting pellet was resuspended in octylglucoside buffer at a concentration of l mg/ml. We added [SH]-cholesterol (250 nmol at 2 ~Ci/umol) to this solution as a lipid marker. The inhibitor was then diluted with an equal volume of 30% (wt/vol) polyethylene glycol 6000, 40% (vol/vol) glycerol in ocytlglucoside buffer. After 30 rain at 4"C with occasional mixing the suspension was centrifuged at 104,000 g for 30 rain. The pellet was suspended in the original volume of octylglucoside buffer and the precipitation with polyethylene glycol was repeated. The final pellet was then resospended in 0.5 ml buffer A and used for growth inhibition studies. Typically, 30% of the protein was recovered, whereas >99% oftbe added [SH]-cholesterol was found in the polyethylene glycol supernatants. 
RESULTS
Effect of SLE on Proliferation of Lymphocytes
SLE (#g/ml)
on mitogen-induced proliferation of both T and B cells isolated from mouse spleen (Fig. 1) . DNA synthesis by B cells treated with 50 /~g/ml anti-IgM or 50 #g/ml LPS was suppressed by 99% upon concurrent addition of 20/~g/ml SLE. T cells treated with l0 #g/ml phytohemagglutinin or 3/~g/ml concanavalin A were also >95% inhibited at a similar dose of SLE. A trivial explanation of this suppression would be a toxic effect of SLE on these cells. This was ruled out by the observation that 20 ~g/ml SLE had no effect on cell viabilities 24 h after addition of SLE to anti-IgM-stimulated B cell cultures (Fig. 2) . It is important to note that the unstimulated cells lost viability quickly, whereas stimulated cells, even in the inhibitory presence of SLE, retained viability comparable to the unsuppressed condition up to 24 h after mitogen addition. A further concern was that the suppressive effect of SLE was not protein mediated, as the extract does contain lipid. Stallcup and various co-workers (24, 25) have demonstrated that a lymphocyte lipid component will inhibit lymphocyte proliferation. As an indication of the fact that the suppressive component is not a lipid, SLE incubated for 15 min at 80"C loses its suppressive activity against fibroblasts (2, 6) . To compare the behavior of SLE with a suppressive lipid, we chose 25-hydroxycholesterol, which is highly suppressive for lymphocytes (26, 27) . While heat-treated SLE lost its suppressive ability, heat treatment of sterol and heat treatment of the combination of SLE and sterol did not affect their ability to inhibit lymphocyte growth (Fig. 3) . Though heat treatment of the SLE ablated its inhibitory capabilities, delipidation did not (Table I) . Furthermore, lipids extracted from SLE by a method similar to that of Stallcup et al. (24) had no suppressive effect (Table I) . Indeed, both the lipid extract and the heated SLE actually had some similar stimu-
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FIGURE 1 DNA synthesis is suppressed in mitogen-activated mouse lymphocytes exposed to SLE. B cells were stimulated with 50 ~.g/ml anti-lgM (A) and 50 ~g/ml LPS (B). These data are representative of five experiments. T cells were stimulated with 3 /~g/ml concanavalin A (C) and 10/~g/ml PHA (D). These data are representative of three experiments. DNA synthesis was assayed as described in Materials and Methods. Both SLE (0, 5, 10, and 20 /~g/ml) and the mitogen were added to the cells at time 0. Means + SEM of triplicates. latory activity. It is possible that this stimulatory component is the same in both cases, and that it is masked by the inhibitory protein in SLE. When the SLE is heated, the inhibitory component is inactivated and the stimulatory component reveals itself. In any case, the data indicate in the lymphocyte system that the SLE suppression is not lipid mediated.
Timing of SLE Effect and Relationship to Early Activation Events
To determine the effective temporal window of SLE's regulatory action, we added SLE to anti-IgM-stimulated B cell The suppressive component of SLE is a protein, not a lipid. B cells were stimulated with 50 ~g/ml anti-lgM and treated as indicated, with 2, 5, and 20 p,g/ml of the following: SLE, heat-inactivated SLE, heat-inactivated SLE + 25-hydroxycholesterol (sterol) (with the sterol at a 10-fold lower concentration than the SLE), and 0.2, 0.5, and 2 ~g/ml heated sterol and unheated sterol. All data are expressed as percent change relative to stimulated, untreated control (5,000 cpm). These data are representative of three experiments. * All data are expressed as percent change relative to control stimulation (9,000 cpm) of DNA synthesis {~H-TdR incorporation after a lO-h pulse with harvest at 72 h--mitogen and inhibitor added at time 0). These data are representative of three experiments. * SLE delipidated with polyethyleneg[ycol as indicated in Materials and Methods. Lipids were extracted from SLE as described by Stallcup et aL (25) . 6 ml of chloroform:methanol (2:1) were added to 0.6 ml of SLE (120 ,~g). After vigorous mixing and 30 min at 4*C, the phases were separated by centrifugation, and the organic layer was obtained. This organic layer was mixed with 3 mI of buffer A, vortexed, and the organic layer obtained once again. The organic layer was then dried down under N~, and resuspended in buffer A using bath sonication at the same volume as the original SLE. Equivalent dilutions to those used in the SLE dose-response curve were then used. ND, not determined.
cultures at varying times after the addition of the mitogen (Fig. 4) . The suppressive action of SLE (10/zg/ml) was greatly reduced if the addition occurred later than 8-12 h after mitogen addition. SLE added 12 h after mitogen addition had only a 22% suppressive effect. This contrasted to 85% suppression when SLE was added with the mitogen at time 0. Since no differences in incorporation relative to control were observed when SLE was added with 3H-TdR at 62 h, we ruled out another trivial explanation: that SLE interferes with 3H-TdR transport or incorporation. The period during which SLE exerts its suppressive effect (0-12 h) is fairly early in the cell cycle. The maximum rate of DNA synthesis occurs 72 h after mitogen addition. Thus, for SLE to inhibit mitogenesis, it must be present early in the cell cycle, a time during which a number of significant metabolic changes are occurring in mitogen-activated cells. Such events, which are associated with the commitment of the cell to enter G 1, include increased synthesis of phosphatidylinositol (15) and an increase in cell size (lymphoblast formation). We examined these events for an effect of SLE to determine whether a specific early response was inhibited. Two different mitogens were used in these experiments. Anti-IgM stimulation of B cells results in a phosphatidylinositol response, whereas LPS treatment does not (15) . The lack of a phosphatidylinositol signal from LPS has been attributed (15) to the ability of LPS to bypass the need for a phosphatidylinositol signal by directly activating protein kinase C (28). Thus, for mitogens which can directly activate protein kinase C, phosphatidylinositol turnover is not an obligatory event; however for those mitogens which do not directly activate protein kinase C, phosphatidylinositol turnover is required to activate this enzyme. Accordingly, antiIgM was used to monitor each of the activation events: phosphatidylinositol turnover, blastogenesis, and DNA synthesis. LPS was used to monitor only the latter two. The incorporation of 32pi into phosphatidylinositol was tested at 2 and 4 h after mitogen addition using a 2-h pulse of 3zPi before cell harvest. During this time period, the metabolism of phosphatidylinositol is the most active of any of the phospholipids (15) . 32pi activity incorporated into phosphatidylinositol increased three-to fivefold in cells stimulated with 50 ug/ml anti-IgM as compared to unstimulated cells. This level of incorporation in the stimulated cells was not altered by the concurrent addition of 20 ~g/ml SLE (Table II) . In contrast, cells treated with LPS and SLE did not substantially enlarge, as compared to control cells treated with LPS alone. As is shown in Fig. 5 , the LPS-stimulated cells had enlarged by 48 h, whereas the cells treated with LPS and 20 ~g/ml SLE had a size profile comparable to cells treated with no mitogen. Aliquots (0.2 ml) of the same cells assayed for cell size enlargement were also assayed for DNA synthesis (data not shown). These same cells treated with 20 #g/ml SLE were, in addition to their lack of a blast response, also >90% suppressed in the later event of DNA synthesis. Though the data shown involves LPS lymphoblasts, the data obtained using anti-IgM stimulated cells was equivalent. No mitogen 2,280 ± 285 8,000 ± 658 50 pg/ml anti-lgM 6,806 ± 1,509 28,090 + 3,166 50 pg/ml anti-lgM + 7,753 ± 1,514 30,432 ± 5,093 10 pg/ml SLE 50 pg/ml anti-lgM + 7,956 _+ 789 31,976 ± 2,450 20 pg/ml SLE "Cells were incubated for the times indicated after mitogen and SLE addition and pulsed with 32Pi 2 h before harvest as indicated in Materials and Methods. All data are cpm 32Pi incorporated into phosphatidylinositol--mean of triplicates + SEM. These data are representative of three experiments.
B Cells Require B Cell Growth Factor for Optimal Mitogenesis
BCOF is thought to be required by the B cell at 4-6 h (19) after mitogen stimulation, which is during the time of the suppressive extract's greatest inhibitory activity. Enriched B cells treated with 30 pg/ml anti-IgM and 10% EL-4-conditioned medium incorporated 32,000 cpm 3H-TdR at 72 h, 170% greater than the 12,000 cpm incorporated by cells stimulated with anti-IgM alone. Though DNA synthesis was greater across the SLE dose-response curve in the BCGFsupplemented cells, the inhibition caused by SLE was comparable at each dose of the inhibitor. 5 ug/ml SLE was 60% suppressive in cultures containing 10% BCGF, as compared to 62% in unsupplemented cells. The percentage suppression by 20 #g/ml SLE was essentially I00% in both instances (<200 cpm).
DISCUSSION
We have examined the suppressive effect of a mouse liver membrane extract on the mitogen-induced proliferation of mouse lymphocytes. This extract inhibited the proliferation of mouse fibroblasts (6) . Four conclusions have emerged from our work. (a) SLE had a strong, dose-dependent, suppressive effect on mitogen-induced proliferation of mouse T and B lymphocytes. Addition of 20 pg/ml (expressed as protein concentration) of SLE caused a 95-99% suppression of DNA synthesis in both T and B cells, regardless of the mitogen used. (b) Loss of suppressive activity upon heat treatment of SLE, together with retention of this activity upon delipidation, indicates that the suppressive factor in SLE is a protein, and not a lipid. (c) The suppressive effect of SLE on mouse lymphocytes extended to movement through G l, as indicated by a failure of B cells treated with both LPS and SLE to undergo blastogenesis. Postponing the addition of the SLE 8-12 h after mitogen addition decreased the suppressive effect significantly. The suppressive effect did not extend to the early event of increased phosphatidylinositol metabolism, which was increased in stimulated cells over unstimulated control cells at 2 and 4 h, but unaffected by concurrent SLE addition.
(d) Addition of B cell growth factor did nothing to relieve the extent of SLE suppression. This experiment suggests that the inhibitory effect of SLE is not a result of a protein in the mixture competing with lymphocyte growth factors for access to the growth factor receptors. The question of a wider applicability of this suppressive phenomenon led us to the experiments with lymphocytes described here. The very fact that a hepatocyte membrane extract is suppressive for fibroblast growth raises the possibility that some cell surface-mediated mechanisms of growth regulation are comparable across a range of cell types including, now, lymphocytes. When SLE was added 12 h after mitogen addition it had little effect on DNA synthesis 60 h later; this observation and the data on viability would seem to rule out a simple toxic effect of the extract on lymphocytes. This is also supported by the fact that SLE had little suppressive effect on human lymphocytes (data not shown). Interestingly, lack of a toxic effect of SLE is further borne out in tests on the one transformed cell line for which we have examined the effect of SLE. EL-4 cells, a murine thymoma line (20) , are completely indifferent to SLE addition (data not shown). This further differentiates our suppressive activity from that of Stallcup et al. (24, 25) growth factor-induced mitogenesis in quiescent cells (29), a situation quite analogous to what we have reported here. The fact that SLE-treated cells failed to enlarge upon mitogenic stimulus, combined with the fact that the greatest suppressive effect on DNA synthesis occurred when SLE was provided within 12 h of the stimulus, indicates to us that the action of SLE is either early in or before G 1, well before the time when the cells have proceeded far enough along the cell cycle to enlarge significantly. The small amount of suppression that did occur upon addition of SLE at a time later than 12 h may be attributable to nonsynchronous lymphocyte growth: at later times these ceils are spread out along the cell cycle to some extent. Extending this examination of activation landmarks, we found no effect of SLE on mitogen-induced activation of phosphatidylinositol turnover. This allows us to narrow the target of the growth inhibitor's effect to a time after entry of the cell into G 1 (marked by increased phosphatidylinositol turnover), but before the later G1 event of cell enlargement.
The The extremely crowded environment of a lymphocyte in a lymph node is a very different one than found in the bloodstream. Though cell culture conditions of necessity resemble the latter, it is in the former that most immune functioning actually takes place. It is also in such a crowded environment that one might expect direct cell contact phenomena, both stimulatory and inhibitory, to be of greatest physiological relevance. In this regard, we note that SLE inhibits progress along the cell cycle well before the cells have accomplished the great internal reorganization that is represented by cellular enlargement. A growth regulator that functions to keep cells in a quiescent state would be expected to act most efficiently by stopping cells early in the cycle.
In summary, we have found a fibroblast growth regulator produced from mouse liver membranes to have significant inhibitory cross-reactivity with cells of the murine immune system. The suppressive effect of SLE is manifested in a late (DNA synthesis) and an intermediate (blastogenesis) event, but not in an early (increased phosphatidylinositol metabolism) event. Experiments in progress include further characterizations of this inhibitor, together wtih explorations into the mechanism by which the factor stops lymphocyte proliferation early in G1.
